Ieq Capital LLC reduced its position in shares of DocuSign, Inc. (NASDAQ:DOCU – Free Report) by 2.6% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 15,828 shares of the company’s stock after selling 416 shares during the period. Ieq Capital LLC’s holdings in DocuSign were worth $1,424,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also added to or reduced their stakes in the company. Toronto Dominion Bank lifted its holdings in shares of DocuSign by 30.3% during the third quarter. Toronto Dominion Bank now owns 26,159 shares of the company’s stock worth $1,624,000 after buying an additional 6,081 shares in the last quarter. Charles Schwab Investment Management Inc. grew its stake in shares of DocuSign by 1.2% in the third quarter. Charles Schwab Investment Management Inc. now owns 1,328,355 shares of the company’s stock valued at $82,478,000 after acquiring an additional 16,014 shares in the last quarter. International Assets Investment Management LLC boosted its holdings in DocuSign by 5,660.8% in the 3rd quarter. International Assets Investment Management LLC now owns 438,914 shares of the company’s stock valued at $27,252,000 after purchasing an additional 431,295 shares during the period. Quantinno Capital Management LP grew its position in shares of DocuSign by 39.5% during the 3rd quarter. Quantinno Capital Management LP now owns 201,546 shares of the company’s stock worth $12,514,000 after purchasing an additional 57,104 shares in the last quarter. Finally, Robeco Institutional Asset Management B.V. increased its holdings in shares of DocuSign by 7.1% during the third quarter. Robeco Institutional Asset Management B.V. now owns 1,296,517 shares of the company’s stock worth $80,501,000 after purchasing an additional 85,987 shares during the period. 77.64% of the stock is currently owned by institutional investors.
Insider Activity
In other news, CEO Allan C. Thygesen sold 7,763 shares of DocuSign stock in a transaction on Monday, December 2nd. The shares were sold at an average price of $80.54, for a total transaction of $625,232.02. Following the transaction, the chief executive officer now owns 100,062 shares in the company, valued at approximately $8,058,993.48. The trade was a 7.20 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Robert Chatwani sold 14,800 shares of the stock in a transaction on Wednesday, December 18th. The shares were sold at an average price of $97.76, for a total value of $1,446,848.00. Following the completion of the sale, the insider now owns 73,414 shares of the company’s stock, valued at $7,176,952.64. The trade was a 16.78 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 693,773 shares of company stock valued at $66,727,926 over the last quarter. 1.66% of the stock is owned by company insiders.
Analysts Set New Price Targets
View Our Latest Stock Analysis on DOCU
DocuSign Stock Down 0.3 %
NASDAQ DOCU opened at $83.69 on Tuesday. The company has a market cap of $16.91 billion, a price-to-earnings ratio of 17.26, a price-to-earnings-growth ratio of 6.94 and a beta of 0.89. DocuSign, Inc. has a twelve month low of $48.70 and a twelve month high of $107.86. The business’s fifty day moving average is $91.45 and its 200 day moving average is $77.09.
About DocuSign
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Featured Stories
- Five stocks we like better than DocuSign
- Buy P&G Now, Before It Sets A New All-Time High
- Finding Hidden Gems: Unconventional Penny Stock Investing
- Health Care Stocks Explained: Why You Might Want to Invest
- Price Targets on NVIDIA Rise in Front of Earnings
- Growth Investing: Should You Adopt This Investing Strategy in 2022?
- Archer Aviation Stock Skids: Mistaking Progress for Bad News?
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for DocuSign, Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for DocuSign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocuSign and related companies with MarketBeat.com's FREE daily email newsletter.